Development and validation of RP-HPLC method for simultaneous estimation of Naproxen and Esomeprazole in pharmaceutical dosage form

Authors

  • Haritha Gali Department of Pharmaceutical Analysis, PNR College of Pharmacy, Shamshabad, RR Dt, Telangana, India
  • Vishwanadham Yerragunta Department of Pharmaceutical Chemistry, Vishnu Institute of Pharmaceutical Education & Research, (VIPER), Narsapur, Medak Dt, Telangana, India

DOI:

https://doi.org/10.56511/JIPBS.2016.v3.i03.pp39-42

Abstract

The objective of the study was to develop a simple, accurate, precise RP-HPLC method for the determination of Esomeprazole and Naproxen using mobile phase (A mixture of Acetonitrile and Methanol in the ratio of 60:40 was considered to be the optimal composition of solvent) as the solvent. The proposed method was involves the measurement of retention time at selected analytical wavelength 260.0 nm was selected as the analytical wavelength. The retention time of Esomeprazole and Naproxen was found to be 3.425 and 4.352. The linearity of the proposed method was in the range of r = 0.9999 for Esomeprazole and r = 0.9999 for Naproxen. The method was statistically validated for its linearity, accuracy and precision of the formulation.

Keywords:

Esomeprazole, Naproxen, RP-HPLC method

Downloads

Download data is not yet available.

References

Skoog D.A., Holler F.J., Nieman T.A.: Principles of Instrumental Analysis 5th edition, 2005; 733-738.

Beckett HA and Stenlake BJ: Practical Pharmaceutical chemistry. CBS Publishers. New Delhi; 4th edition 2003; 168-9.

British Pharmacopoeia: Convention Inc., Rockville, 2008.Vol.I; 965-966.

Sharma BK: Instrumental methods of chemical analysis. Goel Publishers; Meerut, 3rd edition 2005; 861-76.

Gennaro, A.R., Remington. The science and practice of pharmacy, 28th edition, Luppincott, Williams and Wilkins, Baltimore, Maryland, USA, 2000; 534 - 549.

Ghulam A. Shabir: HPLC Method Development and Validation for Pharmaceutical Analysis 2004; 25-27.

International Conference on Harmonization : ICH Q 2 (R1) Validation of Analytical Procedure, Text and Methodology 1995.

British Pharmacopoeia, Stationary office on behalf of Medicine and Healthcare Products Regulatory agency, London UK 13th Edn 2007; (1):373.

The United State Pharmacopoeia. United States Pharmacopoeial Convention Inc. Washington DC, 31st Ed, 2008, Vol. III 2760.

Yerragunta V, Patil P, V. Anusha, T. Kumara Swamy, D. Suman, T. Samhitha: Pyrimidine and Its Biological Activity: A Review. Pharma Tutor 2013; 1(2):39-44.

Chandrakant sojitra and Sadhana rajput: development and validation of rp-hplc methods for simultaneous estimationof naproxen and esomeprazole magnesium trihydrate in combined pharmaceutical formulation. International Journal of Pharmacy and Pharmaceutical Sciences 2012; 4(3):533-537.

Akiful haque, S.Hasan Amrohi, Mahesh Nasare, Prashanth Kumar. K, Pradeep Kumar.T, Nivedita. G and Prakash V Diwan: analytical method development and validation for the estimation of naproxen using rp-hplc. IOSR Journal Of Pharmacy 2012; 4(2):19-24.

Validation of analytical procedure: methodology Q2B, ICH Harmonized Tripartite Guidelines 1996; 1-8.

Published

05-07-2016
Statistics
281 Views | 214 Downloads

How to Cite

Haritha Gali, and Vishwanadham Yerragunta. “Development and Validation of RP-HPLC Method for Simultaneous Estimation of Naproxen and Esomeprazole in Pharmaceutical Dosage Form”. Journal of Innovations in Pharmaceutical and Biological Sciences, vol. 3, no. 3, July 2016, pp. 39-42, doi:10.56511/JIPBS.2016.v3.i03.pp39-42.

Issue

Volume 3, Issue 3, 2016 (Jul-Sep)

Section

Research Article

Copyright (c) 2016 Haritha Gali, Vishwanadham Yerragunta

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.